Inside the Trump-Backed Push to Bring AI Doctors into American Medicine
The administration is laying the groundwork for chatbots that can diagnose illness and prescribe medicine, but physicians say AI can introduce more problems.
Last summer, Amy Gleason became a true believer in the wonders of artificial intelligence.
Her daughter Morgan had spent more than a decade battling a debilitating autoimmune disorder. But when the 27-year-old uploaded 16 years of meticulously kept medical records into ChatGPT, the machine reported that Morgan was suffering from a different ailment than the one diagnosed by doctors. The new assessment granted her entry into a coveted clinical trial.
Gleason is not your typical mom. The leader of the U.S. DOGE Service, which she took over from billionaire Elon Musk, Gleason is now tasked by the Trump administration with bringing AI into the health care system as an adviser to Health and Human Services Secretary Robert F. Kennedy Jr.
She’s part of a cohort of MAHA and tech-alliedofficials who are quietly paving the way for a future in which AI chatbots and robots are an integral part of medical care: diagnosing illness and prescribing medicine with limited or no human oversight. The longtime Silicon Valley dream is taking shape, some entrepreneurs say, thanks in part to a new approach within the Trump administration.
Stay Informed
Sign up to receive updates about our fight for policies at the state level that restore liberty through transparency and accountability in American governance.